This September, I had the absolute privilege of travelling to Miami for the HydroPeptide Global Summit – three incredible days dedicated to product innovation, strategic collaboration, and the long-awaited launch of the Reactivate Rx medical line, more than a year in the making.
Held in the lush surroundings of the Palms Hotel & Spa, the summit brought together HydroPeptide’s global distributors alongside the US team to explore one powerful question:
How do we best serve practitioners – and ultimately, our patients – through science-driven skincare?
It was both a pleasure and an honour to deliver the Keynote Address at this remarkable event.
To stand on stage representing the UK — and to share my journey with HydroPeptide and how it has become so deeply integrated within Dr Lauren Medical Aesthetics and our Skin Suite — was a moment I’ll never forget.
HydroPeptide has been central to our practice for many years, not just because of its results, but because of its philosophy: evidence-based skincare designed for real people, in real clinical settings.
The headline launch of the summit was the debut of Reactivate Rx, a serum and nighttime moisturiser available exclusively to medical professionals.
These formulations represent a new benchmark in regenerative skin health, using HydroPeptide’s signature peptide technology to repair, renew and optimise outcomes at a cellular level.
For me, this line captures everything that makes HydroPeptide special – intelligent innovation, genuine clinical rigour, and a focus on skin that performs as beautifully as it looks.
More than any other brand I’ve worked with in aesthetic medicine, HydroPeptide continues to impress me with its commitment to research, innovation, and real-world outcomes.
This year’s summit didn’t just celebrate what’s been achieved – it set the stage for a bold new chapter in Regenerative Aesthetics.
As Medical Director for HydroPeptide, I couldn’t be prouder or more excited about what’s next.
Here’s to continued collaboration, ongoing discovery – and to Dublin 2026!
